What the buyer wrote
The NHS Commissioning Board (operating under the name of NHS England and NHS Improvement) looks to establish an NHS Framework agreement (on behalf of NHS Trusts) for the supply of drugs licensed specifically to target epidermal growth factor receptor (EGFR)-expressing, RAS wild-type metastatic colorectal cancer. Ref: Tender C1485 Period of framework: 1st December 2020* to 30th November 2022 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 36 months) All documents can be found at:health.atamis.co.uk
Details
- What the buyer calls it
- NHS Framework Colorectal Cancer Drugs (See description below)
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Work starts
- 1 Dec 2020
- Work ends
- 30 Nov 2022
- Kind of work
- Pharmacy and medicines
Who the buyer named
Lynne Nichols was the named contact on this notice.